Status:
RECRUITING
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Thrombotic Thrombocytopenic Purpura (TTP)
Immune Thrombotic Thrombocytopenic Purpura
Eligibility:
All Genders
Brief Summary
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and ischemic organ damage due to mic...
Detailed Description
The TWI-LIGHT protocol is a retrospective, non-interventional epidemiological study coordinated by the French National Reference Center for Thrombotic Microangiopathies (CNR-MAT). It leverages the CNR...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of immune mediated TTP
Exclusion
- Cancer- associated iTTP and HIV-associated iTTP
- Severe sepsis
- Disseminated intravascular coagulation with consumption of coagulation factors;
- Transplant-associated TTP
- HIV-associated TTP (AIDS stage)
- Patient not affiliated with a social security scheme
- Patient or parent's objection to the reuse of their healthcare data for research
Key Trial Info
Start Date :
December 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT07205861
Start Date
December 2 2024
End Date
December 1 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Hématologie Hôpital Saint-Antoine
Paris, France, 75012